US Stock MarketDetailed Quotes
CYDY CYTODYN INC
- 0.129800
- +0.008600+7.10%
15min DelayClose Aug 23 16:00 ET
157.69MMarket Cap-2596P/E (TTM)
0.136500High0.122100Low2.82MVolume0.126900Open0.121200Pre Close364.68KTurnover0.23%Turnover RatioLossP/E (Static)1.21BShares0.41800052wk High-1.35P/B157.59MFloat Cap0.11100052wk Low--Dividend TTM1.21BShs Float3.550000Historical High--Div YieldTTM11.88%Amplitude0.111000Historical Low0.129000Avg Price1Lot Size
About CYTODYN INC Company
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Company Profile
SymbolCYDY
Company NameCYTODYN INC
Founded2002
MarketPink Market
Employees9
Fiscal Year Ends05-31
Address1111 Main Street,Suite 660
CityVancouver
ProvinceWashington
CountryUnited States of America
Zip Code98660
Phone1-360-980-8524
Websitehttp://www.cytodyn.com
Company Executives
- Name
- Position
- Salary
- Dr. Jacob Lalezari
- Interim Chief Executive Officer
- --
- Antonio Migliarese
- Chief Financial Officer
- --
- Bernie Cunningham
- Vice President of Operations
- --
- Cyrus Arman
- Senior Vice President, Business Operations
- --
- Tyler Blok
- Executive Vice President, Legal Affairs
- --
- Tanya Durkee Urbach
- Chairman of the Board
- --
- Stephen M. Simes
- Director
- --
- Ryan Dunlap
- Director
- --
- Lishomwa C. Ndhlovu
- Director
- --
- Karen J. Brunke
- Director
- --
- Joseph Meidling
- Senior Director of Clinical Operations
- --
- Scott Hansen
- Head of Research and Basic Science
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg